YOLFTbeta
30

LIWANLI Innovation Co Ltd

3054 · TW · Healthcare / Drug Manufacturers - Specialty & Generic

59.70TWD+1.40 (+2.40%)

Price History

Full chart

Market Stats

Previous Close58.30
Open58.80
Day Range58.50 – 59.90
52-Week Range22.00 – 96.00
Volume213.25K
Market Cap4.78B
P/E (TTM)12.30
Forward P/E0.00
EPS4.82
Dividend Yield1.34%
Beta-0.47
50-Day Avg53.93
200-Day Avg54.40

About

LIWANLI Innovation Co., Ltd. operates in the biomedical science industry in Taiwan and internationally. The company offers Vigoway and powder collection products for males, females, the elderly, and children. Its products include black elderberry powder, probiotic enzymes, oral care tablets, resveratrol red grape extract, e-soothing powder, tooth guard tablets, bovine and goat's milk bites, bilberry tablets, drops, and other products. The company was formerly known as Carry Technology International Co., Ltd. and changed its name to LIWANLI Innovation Co., Ltd. in 2015. LIWANLI Innovation Co., Ltd. was founded in 1980 and is headquartered in Taipei, Taiwan.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Li-Ching Chen
  • Employees0
  • HeadquartersNo. 537, Tanmei St., Taipei, Taiwan, 114, Taiwan
  • Websitehttps://www.liwanli.com.tw

Leadership

  • Mr. Li-Ching ChenPresident & Chairman
  • Teng-Yin ChangFinance Officer & Accounting Officer
  • Deng Yin ZhangAccounting Supervisor

Financials

Income Statement

Currency: TWD2003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue1.17B823.43M320.65M205.26M509.17M520.22M1.24B1.02B2.32B2.74B2.44B2.24B834.91M323.10M348.21M185.51M129.78M276.88M47.81M33.99M38.89M99.16M125.54M
Growth (%)--29.62%-61.06%-35.98%+148.05%+2.17%+138.96%-18.02%+127.37%+18.10%-10.70%-8.50%-62.66%-61.30%+7.77%-46.72%-30.04%+113.34%-82.73%-28.91%+14.41%+154.98%+26.61%
Cost of Revenue939.32M731.83M253.84M159.02M419.62M391.94M1.10B981.65M2.23B2.68B2.05B2.11B832.13M285.06M399.66M174.09M127.26M301.99M40.27M22.59M23.80M78.32M86.43M
Gross Profit------144.88M37.51M85.28M55.50M392.89M123.22M2.78M38.03M-51.45M11.42M2.52M-25.11M7.54M11.39M15.08M20.83M39.11M
Gross Margin------11.65%3.68%3.68%2.03%16.08%5.51%0.33%11.77%-14.77%6.16%1.94%-9.07%15.77%33.52%38.79%21.01%31.15%
Operating Expense------75.48M75.25M96.40M126.98M166.12M144.47M108.57M59.95M76.95M67.58M-11.02M-8.71M-50.21M131.33M53.40M58.62M109.94M
Operating Income45.90M---939.00K32.78M69.40M-37.74M-11.12M-71.48M226.77M-21.26M-105.79M-21.92M-128.40M-56.16M13.55M-16.41M57.76M-119.94M-38.31M-37.79M-70.83M
Operating Margin3.92%---0.18%6.30%5.58%-3.70%-0.48%-2.61%9.28%-0.95%-12.67%-6.78%-36.87%-30.27%10.44%-5.92%120.79%-352.89%-98.53%-38.11%-56.42%
EBITDA------113.86M165.81M36.88M-24.28M383.58M62.59M-38.75M107.80M119.55M20.30M29.94M-3.06M65.26M-116.86M6.81M-29.23M-68.61M
EBITDA Margin------9.16%16.27%1.59%-0.89%15.70%2.80%-4.64%33.37%34.33%10.94%23.07%-1.10%136.49%-343.82%17.51%-29.48%-54.65%
Net Income32.83M----25.30M86.82M117.29M35.78M-58.15M289.77M15.30M-103.45M62.80M81.91M891.00K2.78M-13.61M45.56M-120.91M5.10M-32.07M158.15M
Net Income Margin2.81%----4.86%6.98%11.51%1.54%-2.13%11.86%0.68%-12.39%19.44%23.52%0.48%2.14%-4.92%95.29%-355.73%13.12%-32.35%125.97%
R&D78.50M105.93M50.26M37.20M24.94M21.82M13.36M11.28M12.04M14.50M19.45M21.45M34.54M29.06M32.71M25.82M17.30M4.29M174.00K87.00K10.00K09.81M
R&D as % of Total Revenue6.71%12.86%15.68%18.12%4.90%4.19%1.07%1.11%0.52%0.53%0.80%0.96%4.14%8.99%9.39%13.92%13.33%1.55%0.36%0.26%0.03%0.00%7.82%
Interest Expense00000029.00K201.00K1.67M2.29M4.28M9.34M9.87M8.75M409.00K296.00K212.00K1.77M512.00K313.00K582.00K517.00K687.00K
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.02%0.07%0.08%0.18%0.42%1.18%2.71%0.12%0.16%0.16%0.64%1.07%0.92%1.50%0.52%0.55%

Balance Sheet

Currency: TWD2003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets1.25B963.72M533.37M741.11M740.41M781.16M1.23B1.03B1.24B1.48B2.14B1.92B1.66B1.74B1.61B1.06B1.13B1.00B947.90M805.93M834.17M792.19M1.14B
Total Liabilities730.38M581.48M70.37M56.55M79.39M114.48M111.57M132.30M435.79M729.07M763.76M677.92M568.28M222.74M71.31M37.01M168.21M67.32M50.38M40.57M50.66M39.23M85.54M
Total Equity520.52M382.24M461.08M682.89M661.02M666.68M1.12B895.33M799.59M753.19M1.38B1.24B1.09B1.51B1.53B1.02B965.79M936.03M897.52M765.36M783.51M752.96M1.06B
Cash151.37M287.63M208.98M412.46M228.51M212.57M293.29M494.16M149.14M210.15M737.78M488.06M359.88M401.43M739.81M301.06M351.68M339.00M216.67M296.94M246.66M248.18M146.37M
Total Debt-------650.00K52.07M287.85M206.40M489.22M151.96M101.46M1.62M1.70M5.96M28.51M3.11M3.12M2.64M1.80M2.70M
Net Debt-------293.29M-493.51M-97.07M77.70M-531.38M1.16M-207.93M-299.97M-738.19M-299.37M-345.72M-310.50M-213.56M-293.82M-244.02M-246.37M-143.67M

Cash Flow

Currency: TWD2003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow--36.62M--50.98M89.43M78.41M-157.77M-104.02M-89.82M473.04M34.04M112.68M96.03M-123.09M-109.16M-36.63M-61.13M78.48M-50.34M14.20M-71.78M
Investing Cash Flow-4.96M27.24M----8.72M138.85M-132.74M-80.45M101.52M-514.62M-157.41M37.76M417.23M146.93M161.73M3.50M45.96M3.39M-24.00K-11.19M-29.59M
Financing Cash Flow205.90M241.92M-261.29M-1.92M--16.39M-54.51M245.49M516.11M-208.35M-6.78M-108.93M-174.85M-462.59M-2.10M21.26M-107.53M-1.40M-469.00K-475.00K-353.00K
Capital Expenditure28.00M17.09M2.39M1.86M86.51M56.83M2.76M81.22M12.23M72.76M23.67M355.89M53.74M5.00K1.97M585.00K4.20M1.68M2.17M387.00K112.00K10.54M4.05M
Free Cash Flow------86.67M-2.81M-170.00M-176.78M-113.49M117.14M-19.70M112.68M94.06M-123.67M-113.36M-38.31M-63.31M78.09M-50.45M3.66M-75.83M
Dividends Paid30.50M8.28M-----16.30M105.54M-159.92M159.92M13.51M13.00M13.00M44.88M-------
FCF to OCF------96.92%-3.59%107.75%169.94%126.36%24.76%-57.85%100.00%97.95%100.48%103.84%104.58%103.56%99.51%100.22%25.76%105.65%
Dividend Paid to FCF--------579.35%-62.08%--140.90%136.51%-68.58%11.54%13.82%-36.29%-------

Earnings

Report DateMar 31, 2003Mar 31, 2004Mar 31, 2005Mar 31, 2008Jun 30, 2008Mar 31, 2009Mar 31, 2011Jun 30, 2011Sep 30, 2011Dec 31, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Jun 30, 2014Sep 30, 2014Dec 31, 2014Mar 31, 2015Jun 30, 2015Sep 30, 2015Dec 31, 2015Mar 31, 2016Jun 30, 2016Sep 30, 2016Dec 31, 2016Mar 31, 2017Jun 30, 2017Sep 30, 2017Dec 31, 2017Mar 31, 2018Jun 30, 2018Sep 30, 2018Dec 31, 2018Mar 31, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Mar 31, 2020Jun 30, 2020Sep 30, 2020Dec 31, 2020Mar 31, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023
EPS Estimate--------------------------------------------------------
EPS Actual2.52-6.35-5.250.070.080.360.37-0.490.440.290.010.06-0.81-0.271.181.021.390.130.340.10-0.07-0.18-0.21-0.22-0.25-0.600.260.070.350.060.51-0.190.350.260.26-0.15-0.240.130.22-0.170.04-0.05-0.190.21-0.260.070.141.31-1.040.13-0.23-0.97-0.15-0.150.20-0.11
Surprise--------------------------------------------------------
Timing--------------------------------------------------------

Key Statistics & Ratios

Market Cap4.78B
Enterprise Value4.01B
Trailing P/E12.30
Forward P/E0.00
PEG Ratio0.00
Price / Sales11.53
Price / Book3.07
EPS4.82
Book Value19.07
Revenue (TTM)414.67M
Gross Profit (TTM)207.46M
EBITDA79.69M
Profit Margin94.47%
Operating Margin27.53%
Return on Equity34.34%
Return on Assets3.71%
Shares Outstanding80.65M
Shares Float15.86M
Beta-0.47
Dividend Yield1.34%
Dividend Rate0.80
Payout Ratio16.61%

Dividends

20182×
2.57Sep 13, 20180.54Jun 28, 2018
20171×
0.15Jul 10, 2017
20151×
0.17Aug 13, 2015
20141×
2.01Jul 28, 2014
20111×
1.83Jul 25, 2011
20101×
0.28Jul 14, 2010
20041×
0.71Aug 19, 2004
20031×
3.29Jul 10, 2003

Stock Splits

  • Sep 13, 2018837:1126
  • Mar 9, 2006691:1825
  • Aug 19, 200427:25
  • Jul 10, 200313:10